Drug intelligence / Profile preview

HoodiadexL10

Development stage
Unknown
Lead developer
Newton-Everett Biotech
Modality
Small Molecules
Administration
Oral
01

Overview

HoodiadexL10 is a dietary supplement marketed primarily for weight management and appetite suppression. It is derived from the *Hoodia gordonii* plant, a succulent indigenous to the Kalahari Desert in Southern Africa. The primary active constituent is a steroidal glycoside designated as P57. The purported mechanism of action involves the modulation of the hypothalamus, where P57 is believed to increase the content of adenosine triphosphate (ATP), thereby mimicking the physiological signal of high blood glucose levels and inducing a state of satiety in the central nervous system. This process results in a reduction of hunger and subsequent caloric intake. HoodiadexL10 is categorized as a nutraceutical and was widely popularized during the mid-2000s as a natural weight-loss aid, although clinical evidence regarding its long-term safety and efficacy in humans remains limited.

Brand names
HoodiadexHoodiadexL10HoodiadexL-10HoodiadexL 10
Other names
Hoodia gordonii extract

Beyond the preview

Go deeper on HoodiadexL10.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HoodiadexL10.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call